| Detected | Trial | Change |
|---|---|---|
| 2026-06-09 | NCT07286214 Sarilumab Efficacy and Safety in Adults With Early Polymyalgia Rheumatica |
Trial sites expanded: 5 -> 9 locations |
| 2026-06-06 | NCT05835986 A First-in-Human Study to Investigate the Safety, Tolerability, Pharmacokinetics and… |
overall status: "Recruiting" → "Active Not Recruiting" |
| 2026-06-06 | NCT07570173 A Clinical Trial of MK-1045 in People With B-cell Acute Lymphoblastic Leukemia… |
date change Primary completion pushed: 2029-02-10 -> 2033-10-18 |
| 2026-06-06 | NCT07570173 A Clinical Trial of MK-1045 in People With B-cell Acute Lymphoblastic Leukemia… |
date change Completion pushed: 2029-10-02 -> 2033-10-18 |
| 2026-06-04 | NCT05091424 A Study Evaluating the Safety, Efficacy, and Pharmacokinetics of Mosunetuzumab and a… |
date change Primary completion pushed: 2028-05-31 -> 2031-02-10 |
| 2026-06-04 | NCT05091424 A Study Evaluating the Safety, Efficacy, and Pharmacokinetics of Mosunetuzumab and a… |
date change Completion pushed: 2030-02-28 -> 2032-02-10 |
| 2026-06-04 | NCT05207670 A Study Evaluating the Safety, Efficacy, and Pharmacokinetics of Mosunetuzumab… |
date change Primary completion moved earlier: 2028-07-31 -> 2027-07-31 |
| 2026-06-04 | NCT05207670 A Study Evaluating the Safety, Efficacy, and Pharmacokinetics of Mosunetuzumab… |
date change Completion moved earlier: 2028-07-31 -> 2027-07-31 |
| 2026-06-02 | NCT06654882 Trial of Sequential Medications AfteR TNFi Failure in Juvenile Idiopathic Arthritis |
date change Primary completion pushed: 2026-06 -> 2026-12 |
| 2026-06-02 | NCT07569081 A Study Evaluating the Efficacy and Safety of Momelotinib in Participants With Vacuoles… |
Enrollment reduced: 192 -> 136 participants |
| 2026-05-30 | NCT04077723 A Study to Evaluate the Safety, Pharmacokinetics and Preliminary Anti-Tumor Activity of… |
Trial sites reduced: 44 -> 35 locations |
| 2026-05-29 | NCT03448042 A Study of Runimotamab in Participants With Locally Advanced or Metastatic… |
date change Primary completion pushed: 2026-11-30 -> 2027-11-30 |
| 2026-05-29 | NCT03448042 A Study of Runimotamab in Participants With Locally Advanced or Metastatic… |
date change Completion pushed: 2026-11-30 -> 2027-11-30 |
| 2026-05-27 | NCT05609630 Study of Oral Upadacitinib and Subcutaneous/Intravenous Tocilizumab to Evaluate Change in… |
Trial sites expanded: 44 -> 56 locations |
| 2026-05-21 | NCT06868290 Phase 2 Study Evaluating Rapcabtagene Autoleucel in Participants With Severe Active GPA… |
Trial sites expanded: 31 -> 35 locations |
| 2026-05-20 | NCT07286214 Sarilumab Efficacy and Safety in Adults With Early Polymyalgia Rheumatica |
Recruitment opened |
| 2026-05-20 | NCT07286214 Sarilumab Efficacy and Safety in Adults With Early Polymyalgia Rheumatica |
Trial sites expanded: 0 -> 5 locations |
| 2026-05-16 | NCT07335562 A Study to Compare the Efficacy and Safety of BMS-986353 (Zolacabtagene- Autoleucel /… |
Recruitment opened |
| First Posted | Trial | Phase | Status |
|---|---|---|---|
| 2026-06-11 | NCT07642076 Evaluation of the Clinical Impact of Adjunctive L-carnitine Therapy in Critically Ill… | Phase 4 | Not Yet Recruiting |
| 2026-06-11 | NCT07643038 Treatment Strategy for Patients With RA-ILD | Phase 4 | Not Yet Recruiting |
| 2026-06-10 | NCT07637578 A Study of Elranatamab Outpatient Administration in Patients With Relapsed/Refractory… | Phase 2 | Not Yet Recruiting |
| 2026-06-09 | NCT07637279 Patient Controlled Propofol Sedation Versus Standard Sedation in Advanced Therapeutic… | Phase 4 | Not Yet Recruiting |
| 2026-06-05 | NCT07629583 To Evaluate the Effects of Cevostamab in Participants With Systemic Lupus Erythematosus… | Phase 1 | Not Yet Recruiting |
| 2026-05-27 | NCT07609940 Adult Outpatient Linvoseltamab With Tocilizumab Prophylaxis to Mitigate the Risk of… | Phase 4 | Not Yet Recruiting |
| 2026-05-26 | NCT07606807 rhTNK-tPA for Acute Ischemic Stroke Under Simplified Imaging in the Extended Time Window | Phase 3 | Not Yet Recruiting |
| 2026-05-19 | NCT07595900 Tocilizumab for the Treatment of Refractory Granulomatous Lobular Mastitis | Phase 1/2 | Not Yet Recruiting |
| 2026-05-18 | NCT07594067 TCR1188-ABC Cells in KRAS-mutated Cancers | Phase 1 | Not Yet Recruiting |
| 2026-05-15 | NCT07589634 A Study Evaluating the Prophylactic Use of Tocilizumab to Prevent Cytokine Release… | Phase 2 | Not Yet Recruiting |
| NCT ID | Title | Condition | Status |
|---|---|---|---|
| Phase 4 | |||
| NCT07286214 | Sarilumab Efficacy and Safety in Adults With Early Polymyalgia Rheumatica | Polymyalgia Rheumatica | Recruiting |
| NCT07542314 | Study to Evaluate the Safety and Effectiveness of ELEVIDYS in Participants With Duchenne… | Duchenne Muscular Dystrophy | Not Yet Recruiting |
| NCT07609940 | Adult Outpatient Linvoseltamab With Tocilizumab Prophylaxis to Mitigate the Risk of… | Relapsed/Refractory Multiple Myeloma (RRMM) | Not Yet Recruiting |
| NCT07637279 | Patient Controlled Propofol Sedation Versus Standard Sedation in Advanced Therapeutic… | Colo-rectal Polyps | Not Yet Recruiting |
| NCT07642076 | Evaluation of the Clinical Impact of Adjunctive L-carnitine Therapy in Critically Ill… | Hepatic | Not Yet Recruiting |
| NCT07643038 | Treatment Strategy for Patients With RA-ILD | Rheumatoid Arthritis Associated Interstitial Lung Disease | Not Yet Recruiting |
| Phase 3 | |||
| NCT06994975 | CHinese ischEmic Stroke Beyond 4.5 Hours With TeNecteplase Under Optimized Non-Contrast… | Acute Ischemic Stroke | Recruiting |
| NCT04088396 | A Study of Baricitinib (LY3009104) in Participants From 1 Year to Less Than 18 Years Old… | Systemic Juvenile Idiopathic Arthritis | Recruiting |
| NCT06954155 | Tenecteplase Reperfusion Therapy in Acute Ischemic Cerebrovascular Events-BEYOND | Stroke | Recruiting |
| NCT07047014 | Advancing Reperfusion Therapy for Ischemic Stroke (ARTS): Tenecteplase in Medium Vessel… | Stroke, Ischemic | Recruiting |
| NCT04871191 | Study of Salvage Therapy to Treat Patients With Granulomatosis With Polyangiitis | Granulomatosis With Polyangiitis | Recruiting |
| NCT06297096 | Study of the Efficacy of Nintedanib+Tocilizumab in Patients With Systemic Sclerosis and… | Systemic Sclerosis | Recruiting |
| NCT04381936 | Randomised Evaluation of COVID-19 Therapy | Pneumonia | Recruiting |
| NCT07509645 | Efficacy and Safety of Interleukin-6 Receptor Inhibitor Combined With Endovascular… | Ischemic Stroke | Recruiting |
| NCT07263776 | Efficacy and Safety of Interleukin-6 Receptor Inhibitor Combined With Endovascular… | Acute Ischemic Stroke | Recruiting |
| NCT07335562 | A Study to Compare the Efficacy and Safety of BMS-986353 (Zolacabtagene- Autoleucel /… | Systemic Sclerosis | Recruiting |
| NCT05609630 | Study of Oral Upadacitinib and Subcutaneous/Intravenous Tocilizumab to Evaluate Change in… | Juvenile Idiopathic Arthritis | Recruiting |
| NCT06654882 | Trial of Sequential Medications AfteR TNFi Failure in Juvenile Idiopathic Arthritis | Polyarticular Course Juvenile Idiopathic Arthritis (JIA) | Recruiting |
| NCT06084936 | A Study to Evaluate Glofitamab as a Single Agent vs. Investigator's Choice in… | Lymphoma | Recruiting |
| NCT07471256 | Neuronavigation-assisted Stereotactic Minimally Invasive Puncture With Tenecteplase for… | Intracerebral Hemorrhage Lobar | Not Yet Recruiting |
| NCT04408638 | A Phase III Study Evaluating Glofitamab in Combination With Gemcitabine + Oxaliplatin vs… | Diffuse Large B-cell Lymphoma | Active, Not Recruiting |
| NCT05171647 | A Study Evaluating Efficacy and Safety of Mosunetuzumab in Combination With Polatuzumab… | Non-Hodgkin Lymphoma | Active, Not Recruiting |
| NCT07281027 | COMparison Between Anakinra and Tocilizumab in NORSE - "COMBAT-NORSE" | New Onset Refractory Status Epilepticus | Not Yet Recruiting |
| NCT07606807 | rhTNK-tPA for Acute Ischemic Stroke Under Simplified Imaging in the Extended Time Window | Acute Ischemic Stroke | Not Yet Recruiting |
| Phase 2/3 | |||
| NCT07302854 | Intra-arterial Recombinant Human Tenecteplase Tissue-type Plasminogen Activator… | Acute Ischemic Stroke | Recruiting |